Tag: Liver Disease: Misc.
FDA Approves Epclusa for Chronic Hepatitis C
Combination drug treats six major strains of hepatitis C virus infection
ALT Levels Within Normal Range Linked to Cardiovascular Events
Incident cardiovascular events were highest for those in the lowest tertile of baseline ALT
Long-Term Pioglitazone Safe, Effective for NASH, T2DM
Safe and effective for patients with prediabetes or type 2 diabetes and nonalcoholic steatohepatitis
Obesity in Older Male Teens Ups Risk for Liver Disease Later
Researchers find odds increase as weight goes up
FDA Approves Ocaliva for Primary Biliary Cholangitis
For patients who have not responded to, or cannot tolerate, ursodeoxycholic acid
Survival for HCV Cirrhosis, SVR Same As General Population
Findings in patients with compensated HCV cirrhosis who achieve SVR on interferon-based regimen
First Case of Paintball-Linked Liver Injury Described
18-year-old male presented with symptoms consistent with acute appendicitis
First-Degree Relative Grafts Don’t Up Liver Disease Recurrence
No difference in autoimmune recurrence, liver graft, or patient survival using first-degree donors
HCV-Infected Liver Transplants Can Work for HCV+ Patients
Findings might help reduce organ waiting list, researchers say
Steatosis in More Than Half of Liver Transplant Recipients
Risk of significant steatosis affected by pre- and post-transplant factors, initial immunosuppression
